Average Co-Inventor Count = 7.26
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Enanta Pharmaceuticals, Inc. (13 from 288 patents)
13 patents:
1. 12281140 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
2. 11958879 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
3. 11718641 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
4. 11040998 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
5. 10968249 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
6. 10947264 - Process for preparation of sulfonylurea bile acid derivatives
7. 10696713 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
8. 10584145 - Process for preparation of sulfonylurea bile acid derivatives
9. 10519191 - Bile acid analogs as FXR/TGR5 agonists and methods of use thereof
10. 10472386 - Bile acid derivatives as FXR agonists and methods of use thereof
11. 10457703 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
12. 10364267 - Deuterated bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
13. 10208081 - Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof